Journey Biosciences and Cardinal Health, Inc. Optifreight Logistics Collaborate to Improve Long-Term Diabetes Care
October 14, 2021 at 10:00 am EDT
Journey Biosciences, Inc. announced a collaboration with Cardinal Health, Inc. OptiFreight Logistics that will increase control and visibility across every transportation modality. The collaboration will deliver Journey Biosciences' critical, first-of-its-kind NaviDKD medical diagnostics screening technology to the point-of-care where innovative testing and risk evaluation takes place using cutting-edge proprietary algorithms, which will enable healthcare providers to more proactively diagnose and manage long-term complications associated with diabetes.